Bernhardt Zeiher

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan Maertens, Issam Raad, Kieren A. Marr et al. · The Lancet · 2015 · 972 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely et al. · The Lancet Infectious Diseases · 2016 · 694 citations

Medicine, Pharmacology, Pharmacotherapy +15

Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel

Peter M. Snyder, Margaret P. Price, Fiona J. McDonald et al. · Cell · 1995 · 413 citations · Full text

Natural Sciences, Genetics, Molecular Biology +12

Neutrophil elastase inhibition in acute lung injury: Results of the STRIVE study

Bernhardt Zeiher, Antonio Artigas, Jean‐Louis Vincent et al. · Critical Care Medicine · 2004 · 347 citations

Medicine, Pharmacology, Pharmacotherapy +13

A mouse model for the delta F508 allele of cystic fibrosis.

Bernhardt Zeiher, E. J. Eichwald, Joseph Zabner et al. · Journal of Clinical Investigation · 1995 · 299 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13